FI902333A0 - Förfarande för framställning av oxoftalazinylättiksyra och dess analoger - Google Patents
Förfarande för framställning av oxoftalazinylättiksyra och dess analogerInfo
- Publication number
- FI902333A0 FI902333A0 FI902333A FI902333A FI902333A0 FI 902333 A0 FI902333 A0 FI 902333A0 FI 902333 A FI902333 A FI 902333A FI 902333 A FI902333 A FI 902333A FI 902333 A0 FI902333 A0 FI 902333A0
- Authority
- FI
- Finland
- Prior art keywords
- analogues
- preparation
- oxophthalazinylacetic
- acid
- oxophthalazinylacetic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/350,997 US4954629A (en) | 1989-05-11 | 1989-05-11 | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
US35099789 | 1989-05-11 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI902333A0 true FI902333A0 (sv) | 1990-05-10 |
FI93959B FI93959B (sv) | 1995-03-15 |
FI93959C FI93959C (sv) | 1995-06-26 |
Family
ID=23379152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI902333A FI93959C (sv) | 1989-05-11 | 1990-05-10 | Förfarande för framställning av oxoftalazinylättiksyra och dess analoger |
Country Status (30)
Country | Link |
---|---|
US (1) | US4954629A (sv) |
EP (1) | EP0397350B1 (sv) |
JP (1) | JPH035479A (sv) |
KR (1) | KR920006419B1 (sv) |
CN (1) | CN1025855C (sv) |
AR (1) | AR246968A1 (sv) |
AT (1) | ATE103913T1 (sv) |
AU (2) | AU618898B2 (sv) |
BG (1) | BG50609A3 (sv) |
CA (1) | CA2016504C (sv) |
CZ (1) | CZ281213B6 (sv) |
DD (1) | DD294257A5 (sv) |
DE (1) | DE69007846T2 (sv) |
DK (1) | DK0397350T3 (sv) |
EG (1) | EG19082A (sv) |
ES (1) | ES2063265T3 (sv) |
FI (1) | FI93959C (sv) |
HU (1) | HU212304B (sv) |
IE (1) | IE62591B1 (sv) |
IL (3) | IL114271A (sv) |
MX (2) | MX167455B (sv) |
NO (1) | NO177708C (sv) |
NZ (1) | NZ233597A (sv) |
PH (1) | PH26567A (sv) |
PL (1) | PL164427B1 (sv) |
PT (1) | PT93985B (sv) |
RO (1) | RO107256B1 (sv) |
RU (1) | RU2014333C1 (sv) |
YU (1) | YU91290A (sv) |
ZA (1) | ZA903565B (sv) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4996204A (en) * | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
IL124236A (en) * | 1997-05-05 | 2003-01-12 | Pfizer | Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor |
EP0982306A3 (en) * | 1998-08-21 | 2000-07-05 | Pfizer Products Inc. | Polymorph of zopolrestat monohydrate |
US8916563B2 (en) | 2010-07-16 | 2014-12-23 | The Trustees Of Columbia University In The City Of New York | Aldose reductase inhibitors and uses thereof |
SI3597650T1 (sl) * | 2010-07-16 | 2023-02-28 | The Trustees Of Columbia University In The City Of New York | Inhibitorji aldoza reduktaze in uporabe le-teh |
CN102558184B (zh) * | 2011-12-30 | 2014-07-16 | 西南大学 | 酞嗪类衍生物的合成方法 |
CN102702108A (zh) * | 2012-06-27 | 2012-10-03 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
CN102863393A (zh) * | 2012-09-26 | 2013-01-09 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
BR112018076244A2 (pt) | 2016-06-21 | 2019-03-26 | The Trustees Of Columbia University In The City Of New York | inibidores da aldose redutase e métodos de uso destes |
RU2020107188A (ru) | 2017-07-28 | 2021-08-30 | Эпплайд Терапьютикс Инк. | Композиции и способы лечения галактоземии |
EP3947391A1 (en) | 2019-04-01 | 2022-02-09 | Applied Therapeutics Inc. | Inhibitors of aldose reductase |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
DE3337859A1 (de) * | 1983-01-21 | 1984-07-26 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von benzthiazolen |
CA1299178C (en) * | 1985-11-07 | 1992-04-21 | Banavara Lakshmana Mylari | Heterocyclic oxophtalazinyl acetic acids |
ES2032749T3 (es) * | 1985-11-07 | 1993-03-01 | Pfizer Inc. | Acidos oxoftalazinil-aceticos heterociclicos. |
JPH0676391B2 (ja) * | 1987-06-09 | 1994-09-28 | フアイザー・インコーポレイテツド | ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法 |
EP0322153A3 (en) * | 1987-12-21 | 1990-08-16 | Pfizer Inc. | Heterocyclic oxophtalazinyl acetic acids |
WO1989006651A1 (en) * | 1988-01-19 | 1989-07-27 | Pfizer Inc. | 1h-indazole-3-acetic acids as aldose reductase inhibitors |
US4996204A (en) * | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
-
1989
- 1989-05-11 US US07/350,997 patent/US4954629A/en not_active Expired - Lifetime
-
1990
- 1990-04-25 ES ES90304441T patent/ES2063265T3/es not_active Expired - Lifetime
- 1990-04-25 AT AT90304441T patent/ATE103913T1/de not_active IP Right Cessation
- 1990-04-25 DE DE69007846T patent/DE69007846T2/de not_active Expired - Fee Related
- 1990-04-25 DK DK90304441.0T patent/DK0397350T3/da active
- 1990-04-25 EP EP90304441A patent/EP0397350B1/en not_active Expired - Lifetime
- 1990-05-02 RO RO144965A patent/RO107256B1/ro unknown
- 1990-05-04 IE IE162690A patent/IE62591B1/en not_active IP Right Cessation
- 1990-05-06 IL IL114271A patent/IL114271A/en not_active IP Right Cessation
- 1990-05-06 IL IL9430190A patent/IL94301A/en not_active IP Right Cessation
- 1990-05-08 CZ CS902278A patent/CZ281213B6/cs not_active IP Right Cessation
- 1990-05-08 NZ NZ233597A patent/NZ233597A/en unknown
- 1990-05-09 PT PT93985A patent/PT93985B/pt not_active IP Right Cessation
- 1990-05-09 PL PL90285113A patent/PL164427B1/pl unknown
- 1990-05-10 NO NO902071A patent/NO177708C/no not_active IP Right Cessation
- 1990-05-10 HU HU902995A patent/HU212304B/hu not_active IP Right Cessation
- 1990-05-10 ZA ZA903565A patent/ZA903565B/xx unknown
- 1990-05-10 CN CN90102797A patent/CN1025855C/zh not_active Expired - Fee Related
- 1990-05-10 EG EG27690A patent/EG19082A/xx active
- 1990-05-10 DD DD90340590A patent/DD294257A5/de not_active IP Right Cessation
- 1990-05-10 FI FI902333A patent/FI93959C/sv not_active IP Right Cessation
- 1990-05-10 CA CA002016504A patent/CA2016504C/en not_active Expired - Fee Related
- 1990-05-10 AU AU54906/90A patent/AU618898B2/en not_active Ceased
- 1990-05-10 RU SU904743977A patent/RU2014333C1/ru active
- 1990-05-10 AR AR90316824A patent/AR246968A1/es active
- 1990-05-10 YU YU91290A patent/YU91290A/sh unknown
- 1990-05-10 KR KR1019900006579A patent/KR920006419B1/ko not_active IP Right Cessation
- 1990-05-10 BG BG091982A patent/BG50609A3/xx unknown
- 1990-05-11 PH PH40512A patent/PH26567A/en unknown
- 1990-05-11 JP JP2122862A patent/JPH035479A/ja active Granted
- 1990-05-11 MX MX020672A patent/MX167455B/es unknown
-
1991
- 1991-10-28 AU AU86806/91A patent/AU626225B2/en not_active Ceased
-
1992
- 1992-12-31 MX MX9207687A patent/MX9207687A/es not_active IP Right Cessation
-
1995
- 1995-06-22 IL IL11427195A patent/IL114271A0/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT87754A (pt) | Process for the preparation of new amino acid derivatives | |
DE69031814D1 (de) | Verfahren zur Herstellung von Polyoxyalkylenderivaten | |
BR8706496A (pt) | Processo para preparacao de compostos e utilizacao | |
PT90637A (pt) | Processo de preparacao de polianidridos | |
PT84790B (pt) | Processo de preparacao de derivados de amino-tiazol e de amino-oxazole e de composicoes farmaceuticas contendo-os | |
FI891074A0 (sv) | Förfarande för framställning av cykliska sulfater | |
BR8905349A (pt) | Processo para a preparacao de uma cicloalcanona e/ou um cicloalcanol | |
PT87153A (pt) | Process for the preparation of acid ribofuranuronic derivatives | |
BR8802843A (pt) | Processo para a preparacao de alcanotriois e alcanopoliois | |
FI935791A (sv) | Framstaellningsfoerfarande av polyhydroxikarboxylsyra | |
DE69027569D1 (de) | Verfahren zur Herstellung von Enynderivaten | |
FI902333A0 (sv) | Förfarande för framställning av oxoftalazinylättiksyra och dess analoger | |
FI91961C (sv) | Förfarande för tillverkning av (S)- -etyl-2-oxo-1-pyrrolidinacetamid | |
FI885692A0 (sv) | Karboximetylsulfoetylcellulosa och förfarande för dess framställning | |
FI880301A (sv) | Aminoplastharts samt förfarande för framställning därav | |
BR8807384A (pt) | Processo para a preparacao de anidridos oxi-diftalicos | |
IT8947842A0 (it) | Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina | |
ZA866809B (en) | Process for the preparation of optically active alpha-phenoxy-propionic acid and its derivatives | |
ZA891534B (en) | Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof | |
FI890477A (sv) | Förfarande för framställning av terapeutiskt användbar 2,5-diamino-6-fluorhexansyra och dess salter | |
PT86776A (pt) | Process for the preparation of piperazinecarboxylic acid and pharmaceutical compositions containing it | |
PT84184A (pt) | Process for the preparation of 8 alpha-acylaminoergolines and of pharmaceutical compositions containing them | |
IT8919339A0 (it) | Procedimento per la preparazione di acido n fosfonometiliminodiacetico e di cloruri di acidi. | |
BR8905815A (pt) | Processo para preparacao de cetoximossilanos | |
IT8621734A0 (it) | Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MM | Patent lapsed |
Owner name: PFIZER INC. |